Graphique du cours de l'action NRSN
NRSN Dividendes
Neurosense Therapeutics Ltd
$0.7
-6.27%
$-0.04
À la fermeture : Jun 29, 16:00:00 GMT-4
$0.7
-0.01%
$0
Post-Marché: Jun 29, 17:14:18 GMT-4
Retour
Neurosense Therapeutics Ltd (NRSN) Dividendes
Statistiques clés
Clôture préc.
$0.7574
Prix d'ouverture
$0.82
Plage de la journée
$0.6942 - $0.95
Plage de 52 semaines
$0.63 - $2.6
Volume
80.4K
Volume moyen
172.7K
Rendement en dividend
--
BPA (TTM)
-0.62
Capitalisation boursière
$25.0M
Qu’est-ce que NRSN ?
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Fonctionnalités
© 2026 Edgen fonctionné par
